| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 7.39e-05 | 12 | 142 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.21e-04 | 14 | 142 | 3 | GO:0097493 | |
| HumanPheno | Long palpebral fissure | 1.02e-05 | 71 | 56 | 7 | HP:0000637 | |
| HumanPheno | Joint hypermobility | CEP104 FLNB DPYD BICRA SPTBN1 NSD1 PTPN22 RFX7 BBS9 FOCAD PIGT PTPN11 KMT2D KMT2A ELN TAF4 VPS37D KIF22 | 1.49e-05 | 557 | 56 | 18 | HP:0001382 |
| HumanPheno | Abnormal nasal bridge morphology | CEP104 TPO FLNB DPYD MAGEL2 WARS1 DYNC2H1 BICRA NEXMIF SPTBN1 GATA4 NSD1 RFX7 BBS9 CASZ1 FOCAD PIGT PTPN11 KMT2D MED12L KMT2A ELN TAF4 FH VPS37D | 2.78e-05 | 1029 | 56 | 25 | HP:0000422 |
| HumanPheno | Large earlobe | 4.46e-05 | 37 | 56 | 5 | HP:0009748 | |
| HumanPheno | Dilatation of the renal pelvis | DYNC2H1 NSD1 XDH PTPN22 RFX7 BBS9 CASZ1 GREB1L FOCAD PTPN11 KMT2D FH | 5.37e-05 | 290 | 56 | 12 | HP:0010946 |
| HumanPheno | Heart murmur | 5.80e-05 | 39 | 56 | 5 | HP:0030148 | |
| HumanPheno | Abnormal eating behavior | 6.58e-05 | 128 | 56 | 8 | HP:0100738 | |
| HumanPheno | Abnormal renal pelvis morphology | DYNC2H1 NSD1 XDH PTPN22 RFX7 BBS9 CASZ1 GREB1L FOCAD PTPN11 KMT2D FH | 7.48e-05 | 300 | 56 | 12 | HP:0010944 |
| HumanPheno | Abnormal heart sound | 8.36e-05 | 42 | 56 | 5 | HP:0031657 | |
| HumanPheno | Abnormality of the chin | MAGEL2 DYM BICRA NEXMIF SPTBN1 NSD1 RFX7 CASZ1 PTPN11 KMT2D MED12L ELN TAF4 VPS37D | 9.36e-05 | 409 | 56 | 14 | HP:0000306 |
| HumanPheno | Vascular dilatation | 9.41e-05 | 215 | 56 | 10 | HP:0002617 | |
| HumanPheno | Irregular ossification of the humeral epiphyses | 1.19e-04 | 2 | 56 | 2 | HP:0003897 | |
| HumanPheno | Abnormal humeral ossification | 1.19e-04 | 2 | 56 | 2 | HP:0012791 | |
| HumanPheno | Frontal bossing | FLNB MAGEL2 DYNC2H1 BICRA SPTBN1 GATA4 NSD1 RFX7 CASZ1 FOCAD PIGT PTPN11 KMT2D MED12L KMT2A ELN FH CUX1 VPS37D | 1.95e-04 | 738 | 56 | 19 | HP:0002007 |
| HumanPheno | Abnormal shape of the frontal region | FLNB MAGEL2 DYNC2H1 BICRA SPTBN1 GATA4 NSD1 RFX7 CASZ1 FOCAD PIGT PTPN11 KMT2D MED12L KMT2A ELN FH CUX1 VPS37D | 2.06e-04 | 741 | 56 | 19 | HP:0011218 |
| HumanPheno | Abnormal frontal bone morphology | FLNB MAGEL2 DYNC2H1 BICRA SPTBN1 GATA4 NSD1 RFX7 CASZ1 FOCAD PIGT PTPN11 KMT2D MED12L KMT2A ELN FH CUX1 VPS37D | 2.10e-04 | 742 | 56 | 19 | HP:0430000 |
| HumanPheno | Epiphyseal dysplasia | 2.54e-04 | 29 | 56 | 4 | HP:0002656 | |
| HumanPheno | Neoplasm of the middle ear | 2.58e-04 | 12 | 56 | 3 | HP:0100799 | |
| HumanPheno | Cholesteatoma | 2.58e-04 | 12 | 56 | 3 | HP:0009797 | |
| HumanPheno | Abnormal ureter physiology | 2.77e-04 | 245 | 56 | 10 | HP:0025634 | |
| HumanPheno | Abnormal morphology of ulna | 3.00e-04 | 159 | 56 | 8 | HP:0040071 | |
| HumanPheno | Abnormality of the ulna | 3.00e-04 | 159 | 56 | 8 | HP:0002997 | |
| HumanPheno | Aplasia/Hypoplasia involving the nose | FLNB DPYD BICRA NEXMIF SPTBN1 GATA4 RFX7 PIGT KMT2D KMT2A ELN TAF4 VPS37D | 3.03e-04 | 401 | 56 | 13 | HP:0009924 |
| HumanPheno | Abnormal size of the palpebral fissures | MAGEL2 WARS1 BICRA SPTBN1 RFX7 KMT2D KMT2A ELN TAF4 CUX1 VPS37D | 3.18e-04 | 298 | 56 | 11 | HP:0200007 |
| HumanPheno | Self-biting | 3.33e-04 | 13 | 56 | 3 | HP:0012169 | |
| HumanPheno | Systolic heart murmur | 3.33e-04 | 13 | 56 | 3 | HP:0031664 | |
| HumanPheno | Neonatal short-trunk short stature | 3.54e-04 | 3 | 56 | 2 | HP:0008857 | |
| HumanPheno | Long phalanx of finger | 3.54e-04 | 3 | 56 | 2 | HP:0006155 | |
| HumanPheno | Large joint dislocations | 3.54e-04 | 3 | 56 | 2 | HP:0005008 | |
| HumanPheno | Abnormal upper lip morphology | FLNB DPYD MAGEL2 DYM WARS1 DYNC2H1 NEXMIF SPTBN1 NSD1 RFX7 BBS9 CASZ1 GREB1L PIGT KMT2D MED12L KMT2A ELN TAF4 CUX1 VPS37D KNL1 | 3.75e-04 | 980 | 56 | 22 | HP:0000177 |
| HumanPheno | High forehead | SPTBN1 GATA4 NSD1 FOCAD PIGT PTPN11 KMT2D MED12L KMT2A ELN VPS37D | 4.00e-04 | 306 | 56 | 11 | HP:0000348 |
| HumanPheno | Abnormal external nose morphology | CEP104 FLNB DPYD BICRA NEXMIF SPTBN1 NSD1 RFX7 CASZ1 GREB1L FOCAD PIGT PTPN11 KMT2D MED12L KMT2A ELN TAF4 FH CUX1 KNL1 | 4.10e-04 | 916 | 56 | 21 | HP:0010938 |
| HumanPheno | Ureteral stenosis | 4.23e-04 | 33 | 56 | 4 | HP:0000071 | |
| HumanPheno | Aortic dilatation | 4.36e-04 | 168 | 56 | 8 | HP:0001724 | |
| HumanPheno | Aortic aneurysm | 4.36e-04 | 168 | 56 | 8 | HP:0004942 | |
| HumanPheno | Facial edema | 4.68e-04 | 129 | 56 | 7 | HP:0000282 | |
| HumanPheno | Hydronephrosis | 5.05e-04 | 264 | 56 | 10 | HP:0000126 | |
| HumanPheno | Dolichocephaly | 5.52e-04 | 219 | 56 | 9 | HP:0000268 | |
| HumanPheno | Disinhibition | CEP104 DPYD ABCA2 MAGEL2 DYM SPR NEXMIF SPTBN1 GATA4 NSD1 RFX7 CASZ1 FOCAD MED12L KMT2A ELN TAF4 VPS37D KNL1 | 6.30e-04 | 807 | 56 | 19 | HP:0000734 |
| HumanPheno | Inappropriate behavior | CEP104 DPYD ABCA2 MAGEL2 DYM SPR NEXMIF SPTBN1 GATA4 NSD1 RFX7 CASZ1 FOCAD MED12L KMT2A ELN TAF4 VPS37D KNL1 | 6.30e-04 | 807 | 56 | 19 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | CEP104 DPYD ABCA2 MAGEL2 DYM SPR NEXMIF SPTBN1 GATA4 NSD1 RFX7 CASZ1 FOCAD MED12L KMT2A ELN TAF4 VPS37D KNL1 | 6.30e-04 | 807 | 56 | 19 | HP:5200123 |
| HumanPheno | Social disinhibition | CEP104 DPYD ABCA2 MAGEL2 DYM SPR NEXMIF SPTBN1 GATA4 NSD1 RFX7 CASZ1 FOCAD MED12L KMT2A ELN TAF4 VPS37D KNL1 | 6.30e-04 | 807 | 56 | 19 | HP:5200029 |
| HumanPheno | Short nose | FLNB DPYD NEXMIF SPTBN1 GATA4 RFX7 PIGT KMT2D KMT2A ELN VPS37D | 6.68e-04 | 325 | 56 | 11 | HP:0003196 |
| HumanPheno | Abnormality of the palpebral fissures | DPYD MAGEL2 WARS1 BICRA NEXMIF SPTBN1 GATA4 NSD1 RFX7 BBS9 PIGT PTPN11 KMT2D MED12L KMT2A ELN TAF4 CUX1 VPS37D KNL1 | 6.79e-04 | 880 | 56 | 20 | HP:0008050 |
| HumanPheno | Abnormal morphology of bones of the upper limbs | FLNB MAGEL2 DYM DYNC2H1 BICRA GATA4 NSD1 PTPN22 PIGT PTPN11 ELN VPS37D KIF22 | 6.83e-04 | 436 | 56 | 13 | HP:0040065 |
| HumanPheno | Abnormality of the humeral epiphysis | 7.02e-04 | 4 | 56 | 2 | HP:0003891 | |
| HumanPheno | Long metacarpals | 7.02e-04 | 4 | 56 | 2 | HP:0010493 | |
| HumanPheno | Short-trunked dwarfism | 7.02e-04 | 4 | 56 | 2 | HP:0003500 | |
| HumanPheno | Pointed chin | 7.04e-04 | 138 | 56 | 7 | HP:0000307 | |
| HumanPheno | Patent ductus arteriosus | GATA4 NSD1 CASZ1 FOCAD PIGT PTPN11 KMT2D KMT2A ELN DNAH9 CUX1 VPS37D | 7.19e-04 | 382 | 56 | 12 | HP:0001643 |
| HumanPheno | Medial flaring of the eyebrow | 7.40e-04 | 228 | 56 | 9 | HP:0010747 | |
| HumanPheno | Abnormal lip morphology | FLNB DPYD MAGEL2 DYM WARS1 DYNC2H1 NEXMIF SPTBN1 GATA4 NSD1 PTPN22 RFX7 BBS9 CASZ1 GREB1L PIGT PTPN11 KMT2D MED12L KMT2A ELN TAF4 CUX1 VPS37D KNL1 | 7.42e-04 | 1249 | 56 | 25 | HP:0000159 |
| HumanPheno | Abnormal forearm bone morphology | 7.44e-04 | 182 | 56 | 8 | HP:0040073 | |
| HumanPheno | Anteverted nares | CEP104 FLNB DPYD BICRA NEXMIF SPTBN1 NSD1 RFX7 PIGT KMT2D MED12L KMT2A ELN TAF4 FH | 7.45e-04 | 559 | 56 | 15 | HP:0000463 |
| HumanPheno | Upturned nose | CEP104 FLNB DPYD BICRA NEXMIF SPTBN1 NSD1 RFX7 PIGT KMT2D MED12L KMT2A ELN TAF4 FH | 7.45e-04 | 559 | 56 | 15 | HP:0000427 |
| HumanPheno | Unilateral renal agenesis | 7.62e-04 | 101 | 56 | 6 | HP:0000122 | |
| HumanPheno | Abnormal renal morphology | FLNB WARS1 DYNC2H1 BICRA NEXMIF GATA4 NSD1 XDH PTPN22 RFX7 BBS9 CASZ1 GREB1L FOCAD PIGT PTPN11 KMT2D TRNT1 ADGRG2 AGXT KMT2A ELN FH VPS37D KNL1 | 7.71e-04 | 1252 | 56 | 25 | HP:0012210 |
| HumanPheno | Abnormal eyelid morphology | FLNB DPYD MAGEL2 WARS1 DYNC2H1 BICRA NEXMIF SPTBN1 GATA4 NSD1 PTPN22 RFX7 BBS9 CASZ1 GREB1L FOCAD TGFBI PIGT PTPN11 KMT2D MED12L KMT2A ELN TAF4 CUX1 VPS37D KNL1 | 7.86e-04 | 1408 | 56 | 27 | HP:0000492 |
| HumanPheno | Ureteral obstruction | 8.10e-04 | 39 | 56 | 4 | HP:0006000 | |
| HumanPheno | Myopia | DPYD MAGEL2 BICRA NSD1 TGFBI PIGT PTPN11 TRNT1 TKFC ZNF644 MED12L ELN VPS37D | 8.65e-04 | 447 | 56 | 13 | HP:0000545 |
| HumanPheno | Radial deviation of finger | FLNB MAGEL2 DYM NEXMIF GATA4 BBS9 CASZ1 PTPN11 KMT2D KMT2A ELN TAF4 VPS37D | 8.83e-04 | 448 | 56 | 13 | HP:0009466 |
| Domain | Post-SET_dom | 2.29e-04 | 16 | 143 | 3 | IPR003616 | |
| Domain | EMI_domain | 2.29e-04 | 16 | 143 | 3 | IPR011489 | |
| Domain | PostSET | 2.29e-04 | 16 | 143 | 3 | SM00508 | |
| Domain | POST_SET | 2.29e-04 | 16 | 143 | 3 | PS50868 | |
| Domain | EMI | 2.76e-04 | 17 | 143 | 3 | PS51041 | |
| Domain | FYrich_C | 5.73e-04 | 5 | 143 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.73e-04 | 5 | 143 | 2 | IPR003888 | |
| Domain | FYRC | 5.73e-04 | 5 | 143 | 2 | SM00542 | |
| Domain | FYRN | 5.73e-04 | 5 | 143 | 2 | SM00541 | |
| Domain | FYRN | 5.73e-04 | 5 | 143 | 2 | PF05964 | |
| Domain | FYRC | 5.73e-04 | 5 | 143 | 2 | PF05965 | |
| Domain | FYRC | 5.73e-04 | 5 | 143 | 2 | PS51543 | |
| Domain | FYRN | 5.73e-04 | 5 | 143 | 2 | PS51542 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 4.69e-05 | 59 | 95 | 5 | M27606 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 6.02e-05 | 32 | 95 | 4 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 6.82e-05 | 33 | 95 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 7.69e-05 | 34 | 95 | 4 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 8.63e-05 | 35 | 95 | 4 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 9.66e-05 | 36 | 95 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 9.66e-05 | 36 | 95 | 4 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.08e-04 | 37 | 95 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 1.08e-04 | 37 | 95 | 4 | M27038 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.33e-04 | 39 | 95 | 4 | M27238 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.39e-04 | 74 | 95 | 5 | M48006 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.47e-04 | 40 | 95 | 4 | MM14945 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 1.62e-04 | 41 | 95 | 4 | M29574 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.62e-04 | 41 | 95 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.78e-04 | 42 | 95 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.95e-04 | 43 | 95 | 4 | MM14609 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.95e-04 | 43 | 95 | 4 | M26975 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 2.05e-04 | 126 | 95 | 6 | M45009 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 2.14e-04 | 44 | 95 | 4 | M109 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.54e-04 | 46 | 95 | 4 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.77e-04 | 47 | 95 | 4 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.77e-04 | 47 | 95 | 4 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.25e-04 | 49 | 95 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.52e-04 | 50 | 95 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.80e-04 | 51 | 95 | 4 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.40e-04 | 53 | 95 | 4 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.73e-04 | 54 | 95 | 4 | M29594 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 5.06e-04 | 149 | 95 | 6 | M4076 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 5.07e-04 | 55 | 95 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 6.22e-04 | 58 | 95 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 6.22e-04 | 58 | 95 | 4 | MM14736 | |
| Pathway | WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME | 7.41e-04 | 106 | 95 | 5 | M40052 | |
| Pathway | REACTOME_TRNA_PROCESSING | 9.12e-04 | 111 | 95 | 5 | M27684 | |
| Pathway | REACTOME_HIV_INFECTION | 9.43e-04 | 231 | 95 | 7 | M12469 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 9.57e-04 | 65 | 95 | 4 | MM15147 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.03e-03 | 114 | 95 | 5 | MM15361 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | AMPH GBF1 BLOC1S4 SPTBN1 PIP5K1C SEC31B PICALM GGA3 SEC23IP CUX1 VPS37D KIF22 | 1.05e-03 | 630 | 95 | 12 | M11480 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 1.11e-03 | 116 | 95 | 5 | M29806 | |
| Pathway | REACTOME_M_PHASE | NUP50 CLASP2 PSMD9 NUP62 POM121C CLIP1 GOLGA8B ANAPC16 NUP153 | 1.18e-03 | 387 | 95 | 9 | MM15364 |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.33e-03 | 71 | 95 | 4 | M27394 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.48e-03 | 73 | 95 | 4 | MM14948 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 GBF1 EP400 BICRA NSD1 C15orf39 CLASP2 BCL9 MBD6 ANKHD1 PIP5K1C POM121C LYST REXO1 CASZ1 GGA3 PPP1R26 FOCAD MST1R TNRC18 KMT2D TKFC UBN1 NAV1 NLRC5 ULK2 | 1.86e-12 | 1105 | 150 | 26 | 35748872 |
| Pubmed | Interaction network of human early embryonic transcription factors. | EP400 BICRA GATA4 C15orf39 PROSER1 BCL9 RFX7 MBD6 POM121C TNRC18 KMT2D ZNF644 KMT2A TAF4 | 4.57e-10 | 351 | 150 | 14 | 38297188 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MAGEL2 GBF1 EP400 PDLIM7 BICRA PTPN22 BCL9 PIP5K1C POM121C PICALM GGA3 TNRC18 UBN1 NEURL4 NUP153 | 6.73e-10 | 430 | 150 | 15 | 35044719 |
| Pubmed | PRR36 MAP6 SPTBN1 NSD1 CLASP2 BCL9 CLIP1 TMEM132B PICALM NOSIP CACNG2 GPR158 SEC23IP NAV1 GOLGA8B TAF4 CAMSAP2 NEURL4 CUX1 NUP153 BEGAIN | 1.21e-09 | 963 | 150 | 21 | 28671696 | |
| Pubmed | ATP5PB EP400 BICRA SPTBN1 GATA4 C15orf39 PROSER1 NUP62 BCL9 RFX7 MBD6 ANKHD1 POM121C NOSIP ZNF771 KMT2D UBN1 DCP1B ZNF644 KMT2A RPRD2 TAF4 CUX1 | 5.41e-08 | 1429 | 150 | 23 | 35140242 | |
| Pubmed | 7.59e-07 | 116 | 150 | 7 | 30804394 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NUP50 SPR SUN1 NUP62 BCL9 ANKHD1 POM121C KMT2D TKFC DCP1B SEC23IP NUP153 | 7.72e-07 | 457 | 150 | 12 | 32344865 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ATP5PB GBF1 DYNC2H1 BICRA CLASP2 CLIP1 FOCAD TGFBI PIGT PTPN11 TKFC SEC23IP TVP23C TAF4 FH CAMSAP2 PCDH9 CUX1 | 8.21e-07 | 1061 | 150 | 18 | 33845483 |
| Pubmed | EP400 PDLIM7 NSD1 ANKHD1 GGA3 PTPN11 KMT2D SEC23IP KMT2A RPRD2 TAF4 AMOTL2 CUX1 | 8.39e-07 | 549 | 150 | 13 | 38280479 | |
| Pubmed | NUP50 WARS1 EP400 SPR BICRA C15orf39 PTPN22 BCL9 NOSIP TNRC18 KMT2D ZNF644 KMT2A TAF4 FKBP5 CUX1 NUP153 KNL1 | 1.42e-06 | 1103 | 150 | 18 | 34189442 | |
| Pubmed | 1.67e-06 | 83 | 150 | 6 | 28794006 | ||
| Pubmed | 2.70e-06 | 268 | 150 | 9 | 33640491 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NUP50 WARS1 EP400 NUP62 ANKHD1 POM121C PICALM GGA3 PTPN11 SEC23IP KMT2A RPRD2 CAMSAP2 NUP153 PARP12 KNL1 | 3.08e-06 | 934 | 150 | 16 | 33916271 |
| Pubmed | DYNC2H1 MUC16 BCL9 POM121C SEC31B CASZ1 NOSIP PIGT KMT2D SEC23IP CUX1 KNL1 FAM149A | 4.35e-06 | 638 | 150 | 13 | 31182584 | |
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 6.96e-06 | 106 | 150 | 6 | 31024071 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 EP400 SPTBN1 BCL9 RFX7 CLIP1 REXO1 KMT2D PTPRC UBN1 ZNF644 KMT2A FKBP5 NUP153 | 7.17e-06 | 774 | 150 | 14 | 15302935 |
| Pubmed | 7.35e-06 | 107 | 150 | 6 | 11347906 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 8.10e-06 | 232 | 150 | 8 | 25515538 | |
| Pubmed | 9.23e-06 | 10 | 150 | 3 | 19581287 | ||
| Pubmed | 1.06e-05 | 114 | 150 | 6 | 21150319 | ||
| Pubmed | EP400 AHCYL2 PIP5K1C GGA3 FOCAD ZNF644 NAV1 CAMSAP2 ULK2 PDZD2 | 1.18e-05 | 407 | 150 | 10 | 12693553 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NUP50 TICRR EP400 NSD1 NUP62 RFX7 POM121C CASZ1 KMT2D UBN1 ZNF644 KMT2A RPRD2 ANAPC16 TAF4 CUX1 NUP153 KIF22 | 1.28e-05 | 1294 | 150 | 18 | 30804502 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.40e-05 | 180 | 150 | 7 | 35198878 | |
| Pubmed | FLNB C15orf39 ANKHD1 GREB1L KMT2D ZNF644 SEC23IP NAV1 CUX1 KNL1 | 1.48e-05 | 418 | 150 | 10 | 34709266 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.61e-05 | 184 | 150 | 7 | 32908313 | |
| Pubmed | 1.62e-05 | 335 | 150 | 9 | 15741177 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.63e-05 | 123 | 150 | 6 | 26912792 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NUP50 EP400 BICRA NSD1 NUP62 PICALM NOSIP UBN1 ZNF644 KMT2A RPRD2 TAF4 CUX1 NUP153 KNL1 | 1.75e-05 | 954 | 150 | 15 | 36373674 |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25410863 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12461747 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12411323 | ||
| Pubmed | Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice. | 1.85e-05 | 2 | 150 | 2 | 31226719 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25834819 | ||
| Pubmed | Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). | 1.85e-05 | 2 | 150 | 2 | 12618768 | |
| Pubmed | Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo. | 1.85e-05 | 2 | 150 | 2 | 26711341 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24423662 | ||
| Pubmed | Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. | 1.85e-05 | 2 | 150 | 2 | 12163599 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 32047502 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24418548 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25307947 | ||
| Pubmed | The Nup153-Nup50 protein interface and its role in nuclear import. | 1.85e-05 | 2 | 150 | 2 | 23007389 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 31398205 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 23597150 | ||
| Pubmed | 2.18e-05 | 13 | 150 | 3 | 16510874 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 2.19e-05 | 38 | 150 | 4 | 12791264 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB DYM BICRA CLASP2 AHCYL2 CASZ1 TNRC18 TRNT1 GPR158 KNDC1 TVP23C NAV1 NLRC5 RPRD2 TAF4 FKBP5 CUX1 PDZD2 FAM149A | 2.39e-05 | 1489 | 150 | 19 | 28611215 |
| Pubmed | 2.69e-05 | 40 | 150 | 4 | 37516964 | ||
| Pubmed | 3.44e-05 | 15 | 150 | 3 | 16510875 | ||
| Pubmed | 3.44e-05 | 15 | 150 | 3 | 14697343 | ||
| Pubmed | ATP5PB FLNB AMPH WARS1 MAP6 SPTBN1 SUN1 AHCYL2 CACNG2 TNRC18 GPR158 AKR7A3 KNDC1 NAV1 CAMSAP2 BEGAIN | 3.56e-05 | 1139 | 150 | 16 | 36417873 | |
| Pubmed | NUP50 GBF1 GATA4 NUP62 PICALM PPP1R26 TNRC18 PTPN11 UBN1 RPRD2 TAF4 KIF22 | 4.77e-05 | 689 | 150 | 12 | 36543142 | |
| Pubmed | NUP50 PDLIM7 SPTBN1 SUN1 PTPN22 CLASP2 PTPN11 KMT2D PTPRC CDC25A NEURL4 FKBP5 NUP153 KNL1 KIF22 | 5.17e-05 | 1049 | 150 | 15 | 27880917 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 19622836 | ||
| Pubmed | Interactions and three-dimensional localization of a group of nuclear pore complex proteins. | 5.53e-05 | 3 | 150 | 2 | 8045926 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 25589673 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 15265786 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 12871362 | ||
| Pubmed | Nitric oxide specifically inhibits integrin-mediated platelet adhesion and spreading on collagen. | 5.53e-05 | 3 | 150 | 2 | 18983487 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 26902498 | ||
| Pubmed | Nup50 is required for cell differentiation and exhibits transcription-dependent dynamics. | 5.53e-05 | 3 | 150 | 2 | 24943837 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 23932714 | ||
| Pubmed | A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15. | 5.53e-05 | 3 | 150 | 2 | 12618766 | |
| Pubmed | AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches. | 5.53e-05 | 3 | 150 | 2 | 34165350 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 26077719 | ||
| Pubmed | Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma. | 5.53e-05 | 3 | 150 | 2 | 31197031 | |
| Pubmed | Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. | 5.53e-05 | 3 | 150 | 2 | 14563646 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 19299707 | ||
| Pubmed | Ameloblastin modulates osteoclastogenesis through the integrin/ERK pathway. | 5.53e-05 | 3 | 150 | 2 | 23385480 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 18552157 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 23132859 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 20351310 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 25415203 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 33372035 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 16113793 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 23192982 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 15928712 | ||
| Pubmed | IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment. | 5.53e-05 | 3 | 150 | 2 | 30794467 | |
| Pubmed | Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia. | 5.53e-05 | 3 | 150 | 2 | 30315824 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NUP50 DYNC2H1 IFFO1 PDLIM7 C15orf39 CLASP2 PSMD9 POM121C BBS9 CLIP1 PIGT DCP1B SEC23IP NAV1 CAMSAP2 NEURL4 PCDH9 | 5.95e-05 | 1321 | 150 | 17 | 27173435 |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 22863532 | ||
| Pubmed | Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation. | 1.10e-04 | 4 | 150 | 2 | 21297004 | |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 22851317 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 37722486 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 28751496 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 20822712 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 15522285 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 1.10e-04 | 4 | 150 | 2 | 23129768 | |
| Pubmed | Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation. | 1.10e-04 | 4 | 150 | 2 | 19192113 | |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 30022050 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 24081332 | ||
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 24739174 | ||
| Pubmed | Mouse neuron navigator 1, a novel microtubule-associated protein involved in neuronal migration. | 1.10e-04 | 4 | 150 | 2 | 15797708 | |
| Pubmed | 1.10e-04 | 4 | 150 | 2 | 24595049 | ||
| Pubmed | 1.31e-04 | 23 | 150 | 3 | 9225980 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP5PB NUP50 FLNB TRAF1 GBF1 WARS1 DYNC2H1 SPTBN1 CLASP2 NUP62 ANKHD1 TGM3 PTPN11 SEC23IP FH NUP153 MGAM2 | 1.48e-04 | 1425 | 150 | 17 | 30948266 |
| Pubmed | 1.69e-04 | 25 | 150 | 3 | 10601273 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | BLOC1S4 PDLIM7 C15orf39 CLASP2 AHCYL2 PICALM DCP1B SEC23IP KNDC1 RPRD2 AMOTL2 CAMSAP2 PARP12 BEGAIN | 1.70e-04 | 1038 | 150 | 14 | 26673895 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.79e-04 | 120 | 150 | 5 | 31413325 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.83e-04 | 361 | 150 | 8 | 30344098 | |
| Pubmed | DSCAM contributes to dendrite arborization and spine formation in the developing cerebral cortex. | 1.83e-04 | 5 | 150 | 2 | 23175819 | |
| Interaction | FEV interactions | EP400 BICRA GATA4 C15orf39 BCL9 KMT2D ZNF644 KMT2A TAF4 CUX1 | 2.32e-06 | 203 | 146 | 10 | int:FEV |
| Interaction | EGR2 interactions | 4.41e-06 | 171 | 146 | 9 | int:EGR2 | |
| Interaction | ASF1A interactions | 1.41e-05 | 249 | 146 | 10 | int:ASF1A | |
| Interaction | CRX interactions | EP400 BICRA GATA4 C15orf39 PROSER1 BCL9 PICALM TNRC18 KMT2D ZNF644 | 1.67e-05 | 254 | 146 | 10 | int:CRX |
| Interaction | TOP3B interactions | ABCA2 GBF1 EP400 BICRA NSD1 C15orf39 CLASP2 BCL9 MBD6 ANKHD1 PIP5K1C POM121C LYST REXO1 CASZ1 GGA3 PPP1R26 FOCAD MST1R TNRC18 KMT2D TKFC UBN1 NAV1 NLRC5 ULK2 | 1.88e-05 | 1470 | 146 | 26 | int:TOP3B |
| Interaction | PHF21A interactions | FLNB TRAF1 C15orf39 PSMD9 NUP62 ANKHD1 KMT2D SEC23IP NAV1 KNL1 KIF22 | 4.19e-05 | 343 | 146 | 11 | int:PHF21A |
| Interaction | DYRK1A interactions | AMPH ABCA2 GBF1 PDLIM7 SPTBN1 RFX7 ANKHD1 PICALM GGA3 KMT2D KNDC1 ANAPC16 CAMSAP2 NUP153 | 4.99e-05 | 552 | 146 | 14 | int:DYRK1A |
| Interaction | NUP35 interactions | NUP50 SPR NUP62 BCL9 ANKHD1 POM121C KMT2D TKFC DCP1B SEC23IP NUP153 PDZD2 | 6.26e-05 | 424 | 146 | 12 | int:NUP35 |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.22e-04 | 25 | 86 | 3 | 775 | |
| GeneFamily | EMI domain containing | 4.62e-04 | 7 | 86 | 2 | 540 | |
| GeneFamily | Nucleoporins | 4.66e-04 | 32 | 86 | 3 | 1051 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.59e-04 | 34 | 86 | 3 | 487 | |
| GeneFamily | PHD finger proteins | 8.93e-04 | 90 | 86 | 4 | 88 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 3.26e-03 | 18 | 86 | 2 | 812 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | TRAF1 IFFO1 BICRA SUN1 GSDMB C15orf39 GAL3ST4 NUP62 MBD6 ZNF467 REXO1 CASZ1 GGA3 PIGT FCGRT SMPDL3A NLRC5 GOLGA8B CUX1 KIF22 | 1.77e-07 | 905 | 147 | 20 | M40865 |
| Coexpression | GSE27786_LIN_NEG_VS_CD8_TCELL_DN | 1.80e-05 | 200 | 147 | 8 | M4777 | |
| Coexpression | GSE17580_TREG_VS_TEFF_DN | 1.80e-05 | 200 | 147 | 8 | M3671 | |
| Coexpression | LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES | 2.01e-05 | 10 | 147 | 3 | M39249 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.29e-06 | 176 | 150 | 7 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-06 | 196 | 150 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.97e-06 | 198 | 150 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.97e-06 | 198 | 150 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Healthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 5.14e-06 | 199 | 150 | 7 | 45e9099a13becb1e235435ceaaffb92b82ce34ee | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 5.14e-06 | 199 | 150 | 7 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 135 | 150 | 6 | 52b5c664c0b7a303c6084d508748dcb6c38a0c23 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-05 | 151 | 150 | 6 | 7b50425d2bbd7b6ff2a6e67d3e2470a4455740e0 | |
| ToppCell | ASK452-Epithelial-Type_2|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.50e-05 | 156 | 150 | 6 | e2b8d65c38cedb8ec6c3c1b138957145af931c51 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type | 2.12e-05 | 166 | 150 | 6 | 96d92316cee20b722fe782db9dafcceb8f2c220b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 171 | 150 | 6 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.59e-05 | 172 | 150 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-05 | 175 | 150 | 6 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-05 | 175 | 150 | 6 | 41174b7381932a2cc94063c7202eeff6d3208cc7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 181 | 150 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 3.45e-05 | 181 | 150 | 6 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 182 | 150 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 182 | 150 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 3.67e-05 | 183 | 150 | 6 | c9e3d91f4c3395a73295b92e25608e0effb5d241 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 150 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Dendritic_Cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.02e-05 | 186 | 150 | 6 | 1d52912bd17e232cf39b2423a4d93585c164ba34 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-05 | 188 | 150 | 6 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.27e-05 | 188 | 150 | 6 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-05 | 190 | 150 | 6 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-05 | 190 | 150 | 6 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-05 | 190 | 150 | 6 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-05 | 191 | 150 | 6 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.80e-05 | 192 | 150 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.94e-05 | 193 | 150 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.94e-05 | 193 | 150 | 6 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.08e-05 | 194 | 150 | 6 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.08e-05 | 194 | 150 | 6 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 194 | 150 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.08e-05 | 194 | 150 | 6 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 5.08e-05 | 194 | 150 | 6 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | Healthy-Classical_Monocyte|World / disease group, cell group and cell class | 5.23e-05 | 195 | 150 | 6 | 0d96f456cc84ebb2543406fb2374c6d7cedd3c4d | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-05 | 195 | 150 | 6 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 5.38e-05 | 196 | 150 | 6 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.53e-05 | 197 | 150 | 6 | 2afc23f7394d9b40bdf06527c5e6b553e1b02dca | |
| ToppCell | COVID-19_Severe-Myeloid-Non-classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class | 5.53e-05 | 197 | 150 | 6 | c5837b9a5a39a0f607a4e217ade9fc87d82a5406 | |
| ToppCell | Monocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.53e-05 | 197 | 150 | 6 | 3388c104af4c6a05988e102627e0c5e34d9dcc45 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 5.53e-05 | 197 | 150 | 6 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | mild_COVID-19-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 5.53e-05 | 197 | 150 | 6 | 5d826f4d7b7a46847c67e6bef38eb860bc808a6c | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.69e-05 | 198 | 150 | 6 | 9b8679b3dd8f4220d71f607b7080cb88d6e71129 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.69e-05 | 198 | 150 | 6 | 8b6b602ebe59b6dca6a22f17385d3160ff3ac67e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-05 | 198 | 150 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.69e-05 | 198 | 150 | 6 | b9030390316baf456135f85f831394e1e11ecf3e | |
| ToppCell | severe-dn_T|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.69e-05 | 198 | 150 | 6 | d4f2213af45ada47e6c62675f468ce05692db507 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-05 | 198 | 150 | 6 | 33690e16e4549b110e5b67f84b9515c696fe05e1 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.69e-05 | 198 | 150 | 6 | d36a3cda7e5f385d2391e9b0dfb027d3c4549320 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.69e-05 | 198 | 150 | 6 | 5436c3ed16e10e00c686f1ab0b0a68728a1a9985 | |
| ToppCell | mild_COVID-19-Classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.69e-05 | 198 | 150 | 6 | 5b31b6e008e05d6528656114fbe0ccae8ffe13b1 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.69e-05 | 198 | 150 | 6 | 4f67067d8142ca11b2d80195dac8d62a8d24d52c | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.85e-05 | 199 | 150 | 6 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-05 | 199 | 150 | 6 | beca4c7eb29ac771fd37f30cd23d4dce4afcfff8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-05 | 199 | 150 | 6 | cd3ab9a75b40e0d417d53b3d8756fc9bed30ac83 | |
| ToppCell | Healthy/Control-Classical_Monocyte|World / Disease group and Cell class | 5.85e-05 | 199 | 150 | 6 | 527c767a09f911e319f7ad230b6518cebc0f367d | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.85e-05 | 199 | 150 | 6 | 96dfbcf5261286f17d9718b04ebb7b288d229b52 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-05 | 199 | 150 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Healthy_donor-Classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 5.85e-05 | 199 | 150 | 6 | af3a80dbf5e0306b80f420fd41f1aaed81fe9c46 | |
| ToppCell | Healthy/Control-Classical_Monocyte|Healthy/Control / Disease group and Cell class | 5.85e-05 | 199 | 150 | 6 | 4e8c7445d32fd2b7a50524dcd52141e76850c3df | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.85e-05 | 199 | 150 | 6 | fa5ad81554969fffe5e779614d071d9194a7182c | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.85e-05 | 199 | 150 | 6 | 87d513a521dd0359f4f79b01e9e97eacb0a3c6e2 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | 5f41906cf1585e09b150a84364d47c3e466dc5b7 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | 83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class | 6.02e-05 | 200 | 150 | 6 | 58fbb7fc7159cbc417e6b457d60b7beba9b90da6 | |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T|COVID-19_Severe / Disease, condition lineage and cell class | 6.02e-05 | 200 | 150 | 6 | d01aa5fccada22f97d8350ad5888df2aadb5bb1c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | mild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 8a480f487b52938d00b53bf4b18f067353d34419 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | severe-Non-classical_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 6cc7190a4ffc6c06335072f3b5b5f98eae36e2ce | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | f7a9d8b99de19e9842422bada348d940e0863645 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.02e-05 | 200 | 150 | 6 | 4243a9d32f3a11141284d0d944cb81194b532876 | |
| ToppCell | (51)_cDC1|World / shred on Cell_type and subtype | 6.71e-05 | 204 | 150 | 6 | a8cf4180c406674b7541917d1fc6127686ba5f8a | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.16e-04 | 141 | 150 | 5 | b2857b73fd754b879b922c7720b5ac3024976822 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 142 | 150 | 5 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 147 | 150 | 5 | c8e5bdc3538089acd35a4b41390afaec0ac6d1aa | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 153 | 150 | 5 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | droplet-Fat-SCAT-30m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 153 | 150 | 5 | 2731c3d4ac40ecc22108f8f3f45a069077159125 | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.80e-04 | 155 | 150 | 5 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.86e-04 | 156 | 150 | 5 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 156 | 150 | 5 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.86e-04 | 156 | 150 | 5 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.86e-04 | 156 | 150 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 157 | 150 | 5 | d2cb261a9ee2c90e2e0fc656bd6413fbccb465fc | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 157 | 150 | 5 | 350069e4d2dbddc82e813e2a2cc43032daa23605 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-04 | 158 | 150 | 5 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-04 | 159 | 150 | 5 | c960df9e4fa980401941866b5081facac4590b4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 160 | 150 | 5 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| Drug | copper fluoride | 3.52e-06 | 17 | 145 | 4 | CID000082236 | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.19e-06 | 198 | 145 | 9 | 5526_DN | |
| Disease | lymphocyte count | FLNB TRAF1 GBF1 PCDHGB2 NSD1 GSDMB PTPN22 RFX7 LYST CASZ1 FOCAD MST1R PTPRC ZNF644 MED12L NLRC5 NEURL4 FKBP5 PARP12 KNL1 | 3.04e-05 | 1464 | 144 | 20 | EFO_0004587 |
| Disease | Disproportionate short stature | 3.85e-05 | 77 | 144 | 5 | C0878659 | |
| Disease | Malignant neoplasm of breast | FLNB DPYD WARS1 DYNC2H1 PDLIM7 GSDMB XDH CLIP1 GGA3 KMT2D PTPRC ZNF644 NLRC5 DNAH9 CUX1 NLRP8 | 7.45e-05 | 1074 | 144 | 16 | C0006142 |
| Disease | Weaver syndrome | 2.34e-04 | 5 | 144 | 2 | C0265210 | |
| Disease | clubfoot (is_implicated_in) | 2.34e-04 | 5 | 144 | 2 | DOID:11836 (is_implicated_in) | |
| Disease | bitter non-alcoholic beverage consumption measurement | 5.09e-04 | 32 | 144 | 3 | EFO_0010093 | |
| Disease | photoreceptor cell layer thickness measurement | 8.16e-04 | 148 | 144 | 5 | EFO_0803370 | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 8.33e-04 | 9 | 144 | 2 | EFO_0800314 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 8.47e-04 | 38 | 144 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | theophylline measurement | 1.04e-03 | 10 | 144 | 2 | EFO_0021180 | |
| Disease | glucagon-like peptide-1 measurement | 1.04e-03 | 10 | 144 | 2 | EFO_0008465 | |
| Disease | aortic stenosis, aortic valve calcification | 1.14e-03 | 42 | 144 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.26e-03 | 11 | 144 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | campesterol measurement | 1.26e-03 | 11 | 144 | 2 | EFO_0020008 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.33e-03 | 335 | 144 | 7 | EFO_0009931 | |
| Disease | Diuretic use measurement | 1.47e-03 | 169 | 144 | 5 | EFO_0009928 | |
| Disease | insomnia measurement | 1.54e-03 | 443 | 144 | 8 | EFO_0007876 | |
| Disease | Leukemia, Myelocytic, Acute | 1.63e-03 | 173 | 144 | 5 | C0023467 | |
| Disease | tetralogy of Fallot (is_implicated_in) | 1.78e-03 | 13 | 144 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | Diverticular Bleeding | 1.78e-03 | 13 | 144 | 2 | C4505353 | |
| Disease | Diverticular Diseases | 1.78e-03 | 13 | 144 | 2 | C4317009 | |
| Disease | serum non-albumin protein measurement | 2.03e-03 | 361 | 144 | 7 | EFO_0004568 | |
| Disease | precuneus cortex volume measurement | 2.07e-03 | 14 | 144 | 2 | EFO_0010326 | |
| Disease | lateral ventricle volume change measurement | 2.38e-03 | 15 | 144 | 2 | EFO_0021502 | |
| Disease | Beta blocking agent use measurement | 2.40e-03 | 114 | 144 | 4 | EFO_0009929 | |
| Disease | temporal arteritis (is_implicated_in) | 2.71e-03 | 16 | 144 | 2 | DOID:13375 (is_implicated_in) | |
| Disease | response to opioid | 3.33e-03 | 61 | 144 | 3 | EFO_0008541 | |
| Disease | Acute Myeloid Leukemia, M1 | 3.34e-03 | 125 | 144 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 3.34e-03 | 125 | 144 | 4 | C1879321 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.83e-03 | 19 | 144 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Thyroid preparation use measurement | 4.33e-03 | 217 | 144 | 5 | EFO_0009933 | |
| Disease | mean platelet volume | GP6 BLOC1S4 PCDHGB2 SPTBN1 GATA4 ITGA2 PICALM PTPRC UBN1 ULK2 CUX1 VPS37D | 4.36e-03 | 1020 | 144 | 12 | EFO_0004584 |
| Disease | cytotoxicity measurement, response to metformin | 4.67e-03 | 21 | 144 | 2 | EFO_0006952, GO_1901558 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APKGFLLLSPTSSNA | 56 | Q6ZS49 | |
| TLLAPLNSVFKDGTP | 411 | Q15582 | |
| SLRPAKSVPSVFAAA | 661 | Q9Y2J4 | |
| AIATQLPPKVSAAFS | 461 | Q96L91 | |
| SGFSVSDLAPPRKAL | 21 | Q96DE5 | |
| TKAIPLFGNSLKPDS | 76 | O95154 | |
| TKNAVLTYPSPAALG | 751 | Q9NQ75 | |
| SLFSKSAPSRPQQAG | 181 | Q9NUP1 | |
| SPRFAKATAAVAAPL | 346 | Q9BUH8 | |
| PGLKPFLQSAAATTN | 121 | Q9NP70 | |
| AAAALKPSATFDPGS | 881 | Q86V15 | |
| ASPSLPLASTGKFAL | 466 | P39880 | |
| PDKPLLSSLFNAAGV | 311 | Q8TAX9 | |
| PAKLSVVSFAPSSNG | 51 | Q8IZP9 | |
| LGSLFSTLKPPDAVF | 316 | P35368 | |
| KFINPFGLASATPAT | 541 | Q12882 | |
| EANPAKVLASSLSPF | 436 | Q9C0I3 | |
| ASFPNKGVTSIIPAI | 76 | O60397 | |
| SAAKFAPSPATAQLA | 16 | Q8NB25 | |
| ATAAPSLKNAAFLGP | 11 | P24539 | |
| KAFTIQGAPSDSGPL | 241 | P49418 | |
| GNNITSAPPFASAKA | 91 | Q9UKX7 | |
| GSNEKAALLPAPFSL | 246 | Q96L73 | |
| AGEFSPNVPKSLSSA | 631 | Q9Y2R2 | |
| LNPFTAKALSGTSPD | 126 | Q9Y314 | |
| DASPVGIKGFNTLPS | 251 | Q9Y698 | |
| AGSLPKIPSNATLFF | 116 | Q13451 | |
| LGASKTPASIFGPSA | 13771 | Q8WXI7 | |
| AVPANAFDSTPNLKG | 536 | Q7Z5L7 | |
| PPFLASSLLSAAAKA | 316 | Q96DN6 | |
| PAGSFVPTNTKQALS | 1841 | Q86YW9 | |
| SAASQASAPILGAPK | 181 | Q96JE9 | |
| FQPASLNAFKGPSAA | 796 | Q9UJ55 | |
| LNAFKGPSAASETPK | 801 | Q9UJ55 | |
| TAQLKRLPSPSLFGN | 106 | Q2M2H8 | |
| LLAKLFETSTAPPAG | 11 | A5PLN7 | |
| TNSVLGPPFLKALAA | 711 | Q86W28 | |
| SLKRPPTAGAQFKSS | 556 | Q9UBC5 | |
| PASSALSANKIAGPR | 1191 | Q5T848 | |
| TLPTNASIKFNPGAE | 116 | Q13201 | |
| KGSPVNSLFVAPAVT | 306 | Q92484 | |
| PKDNSTIRALFPSLG | 366 | Q9H9K5 | |
| AAGSSAPKPAFAKVL | 11 | A6NLJ0 | |
| KSLFCLPTGGPSLAS | 361 | Q86V42 | |
| VATGVFAKPSLSAQP | 106 | Q9HCN6 | |
| LGPDNTSVPTAKFAL | 121 | P55899 | |
| KSPFTVGVAAPLDLS | 931 | O75369 | |
| SIPNPSIISSKLGGF | 81 | A8MYZ0 | |
| AGVPFASDTILKQAP | 796 | Q9Y5G2 | |
| NTSFKLVPLSAIPGS | 681 | Q9HC56 | |
| LIPGLSQKPISSFAD | 206 | Q14807 | |
| ANADRPVAKSGASPF | 2346 | O15018 | |
| FGNKIGSSPSPAALS | 121 | Q96LB9 | |
| AQLLSFSKLPEPTSG | 71 | P07202 | |
| SPGFLNEPLSSKSQR | 1076 | Q8NG31 | |
| SSLFSTGVAPALAPK | 481 | Q9NZ52 | |
| SPPALSAALVAKGTS | 651 | Q6ZVL6 | |
| ARPSKSNPGDFTLSV | 31 | Q06124 | |
| AQAFLKLLSSSNPPT | 121 | Q6ZUF6 | |
| STTGFALNLKPLAPA | 286 | P37198 | |
| KSPSLAAFLANPRGF | 181 | Q96RP7 | |
| NLNAVKSPIFTPSSG | 1511 | Q9C091 | |
| NVGLPEAKIFSGPSS | 31 | P17301 | |
| AGPFTKAASEPLSRA | 116 | Q969R2 | |
| FAPSVSLNKTARPFG | 106 | Q9NR12 | |
| DTNKSPVSLLSLFPG | 551 | Q3SYG4 | |
| SQTGLSPKSPFLLAN | 1171 | Q86WI3 | |
| SALPDPGFQKITLSS | 491 | Q9H0J9 | |
| TLFASPPAKSTANGN | 91 | A8CG34 | |
| NSASLSSVFAGLPLP | 421 | Q86XN7 | |
| QSGDRKSPAFTAVPL | 521 | Q0D2I5 | |
| PALAAKFPVLAQSSG | 471 | Q8IZD4 | |
| SALKLSPQGYASPVS | 401 | P43694 | |
| DKPSFFGLPANIARS | 3991 | Q8NCM8 | |
| KAPALQPGKSSAVAA | 881 | O60308 | |
| VGSKAAASPELSSPL | 266 | Q7RTS9 | |
| KVAALTGLPFVTAPN | 296 | P07954 | |
| AAASIKSPPVLGSAA | 901 | O00512 | |
| PESSLAPAVAALKAA | 121 | P35452 | |
| NVLKSIPASFGTRAP | 1701 | Q9BZC7 | |
| SIAGPRKFPLAQTES | 2591 | Q99698 | |
| SIENLPSVFGSNPKA | 991 | Q92538 | |
| TSQSLFPSASKGLLP | 3141 | Q03164 | |
| FKVVNGQASPSPSTA | 956 | Q76NI1 | |
| VSFSAGLTQKPFPSD | 906 | Q9BXX0 | |
| NLTELKSFGSPPLAV | 3171 | Q9NYC9 | |
| KSFGSPPLAVSNVSA | 3176 | Q9NYC9 | |
| QVPLNPFSFTLSGKS | 191 | Q1W209 | |
| GKFLAAARNPAAEPS | 506 | A8MQT2 | |
| ANVFKQPPATTTGAA | 421 | Q9NZM4 | |
| NLPTLNVAKAASSGP | 1041 | Q9NZM4 | |
| SSPRVPGALAAAKAA | 641 | P15502 | |
| GLPSTTFKLPSNSLG | 616 | Q5VT52 | |
| AKASDGSVPLPLQFL | 2271 | Q6ZTR5 | |
| PSKQAGLSSAIAPFS | 946 | Q08AD1 | |
| LQSKLSSSGAPPADF | 951 | Q8NG08 | |
| PSVLDFPSSATGLKG | 111 | Q96JN8 | |
| IGFPSTTPAKAKANA | 281 | P30622 | |
| VAVFKAASPLGSPEL | 1491 | Q5VW36 | |
| PRAGASPATSKTLAF | 16 | Q8TBJ5 | |
| PASQPVVKALFGASA | 21 | P30304 | |
| RATAKSFVKPPSLAN | 786 | Q8NEY1 | |
| FAKVNSISPGSPASI | 136 | O00233 | |
| GKISFPAIQAAPSFS | 276 | P23381 | |
| PAVLPGTKALSAVSA | 796 | O00268 | |
| AAPAEPGSKYSLASL | 171 | Q8N1G1 | |
| LNAPPGTSLISFSDK | 211 | P21549 | |
| DGFSPKPVTLLASLF | 286 | Q96Q11 | |
| AALSPAAGKVPQASA | 71 | Q96HN2 | |
| LKSGGPDAFTSFPTQ | 861 | Q14DG7 | |
| ALEPAFGKISPLSAD | 121 | Q8TDR4 | |
| LSPAFPSLIKNTGVA | 506 | Q5VVP1 | |
| PGKNIFFSPLSISAA | 71 | P29622 | |
| KSFAALEAAAPIQPT | 36 | Q5QGS0 | |
| VKPLGPTAAFSASQI | 466 | O60331 | |
| ATSLGNSAFPLAALP | 471 | Q9H6K5 | |
| AAKFPEAVLAAGLTP | 421 | Q86YJ6 | |
| PAAKSAFGQLPSCAT | 971 | Q5T8A7 | |
| ADKISSSFSKGQPLP | 346 | Q9NQW1 | |
| TSVGQSGFPKPLTAL | 106 | Q9Y6Y8 | |
| LSFPQSKANLASVAP | 386 | Q5PT55 | |
| AKTALPAQSAATLPA | 2176 | Q01082 | |
| ALGKLKPNTPFAATS | 456 | Q08188 | |
| ASSKNAFPLGAPTLV | 1801 | Q8IWZ3 | |
| DGNRPSSAASAFKVP | 16 | O75122 | |
| LAPAPSKGQTLDGTF | 176 | Q6ZRI6 | |
| FSPAPKATLILNSIG | 166 | Q9Y242 | |
| DAIPSLNPFLTKSSG | 431 | Q13492 | |
| GAPSKVDSSFQLPAK | 31 | Q15735 | |
| AGPSAQAALPTKATK | 2691 | O15417 | |
| ALTQSPLLFQGKTPS | 1846 | Q7Z2Z1 | |
| KVLGSRDPPASAFQS | 166 | Q96ET8 | |
| FKLPPGATAATATER | 296 | Q7L3S4 | |
| VTPTASFKPLGLAND | 151 | Q969N2 | |
| SSVLKAFPDSPGLNR | 136 | P35270 | |
| ASGCPLFFPLSKLQS | 381 | Q13077 | |
| ASKAVGEPPLFLAAS | 1256 | P47989 | |
| FAVPAPLDNKGTNSS | 1046 | Q2KHR2 | |
| SPPKEFLLGSSSAQA | 131 | O95473 | |
| KSFPAAAVLPTGAAR | 191 | Q86XT2 | |
| GFASPKIDSVAAQPT | 616 | P49790 | |
| PTVSSENFILPKGAA | 101 | Q9H582 | |
| APPAGTAASSKAVLF | 711 | Q8IYT8 | |
| RAAGNSEFTLPAPSK | 686 | Q9NPG3 | |
| ALLLAFLPPASQKSS | 6 | A0A0C4DH27 | |
| FLPPASQKSSNLEGR | 11 | A0A0C4DH27 | |
| SPTGNISSAPKDFAV | 701 | O94901 | |
| FRPGFSPTADSLALK | 781 | Q9BXT5 | |
| TAAAQPLKAKTSLPA | 456 | Q3LXA3 | |
| TFSGSAANAKLNPTP | 126 | P08575 | |
| KPSASFGSPVQSEAL | 751 | Q6BDS2 | |
| SGFAPGFVALSVLPK | 226 | Q04912 | |
| LINSKPSVFHGPSQA | 351 | O94900 | |
| SSSPSPALNGVRKDF | 161 | O14544 | |
| LGATVDAPAAKPLAS | 391 | Q7Z7K2 | |
| TPAGLSTSADGFLKP | 2131 | O14686 |